Comparative efficacy and safety of pathway-targeted pharmacotherapies for Alzheimer's disease: A systematic review and network meta-analysis of phase III trials.
- DOI
- 10.1016/j.arr.2026.103216
- Published
- 2026 Aug
- Container
- Ageing research reviews
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.arr.2026.103216,
title = {Comparative efficacy and safety of pathway-targeted pharmacotherapies for Alzheimer's disease: A systematic review and network meta-analysis of phase III trials.},
author = {Wu Y and Di Y and Wang H and Wang L and Zhang J and Zhang Y and Lyu D},
year = {2026},
journal = {Ageing research reviews},
doi = {10.1016/j.arr.2026.103216},
url = {https://doi.org/10.1016/j.arr.2026.103216}
}RIS
TY - JOUR TI - Comparative efficacy and safety of pathway-targeted pharmacotherapies for Alzheimer's disease: A systematic review and network meta-analysis of phase III trials. AU - Wu Y AU - Di Y AU - Wang H AU - Wang L AU - Zhang J AU - Zhang Y AU - Lyu D PY - 2026 JO - Ageing research reviews DO - 10.1016/j.arr.2026.103216 UR - https://doi.org/10.1016/j.arr.2026.103216 ER -
APA
Y, W., Y, D., H, W., L, W., J, Z., Y, Z., & D, L. (2026). Comparative efficacy and safety of pathway-targeted pharmacotherapies for Alzheimer's disease: A systematic review and network meta-analysis of phase III trials.. Ageing research reviews. https://doi.org/10.1016/j.arr.2026.103216
Source records
- pubmed · retrieved 2026-09-25T10:39:45.515Z